Mark Baldry

Insider Reports History

Location
Cranbury, NJ
Signature
/s/ Adam S. Mostafa, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Baldry:

Stock Role Class Num Shares Value Price $ Report Date Ownership
X4 Pharmaceuticals, Inc Chief Commercial Officer Common Stock 25.3K $62.9K $2.48 16 May 2025 Direct

Insider Reports Filed by Mark Baldry

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XFOR X4 Pharmaceuticals, Inc 16 May 2025 1 $2.56K 4/A Chief Commercial Officer 03 Jun 2025, 17:01
XFOR X4 Pharmaceuticals, Inc 23 Jan 2025 2 -$13.2K 4 Chief Commercial Officer 27 Jan 2025, 18:15
XFOR X4 Pharmaceuticals, Inc 04 Oct 2024 2 -$6.51K 4 Chief Commercial Officer 08 Oct 2024, 16:44
XFOR X4 Pharmaceuticals, Inc 17 May 2024 3 $19.3K 4 Chief Commercial Officer 14 Feb 2025, 16:08
XFOR X4 Pharmaceuticals, Inc 13 Feb 2024 1 $0 4 Chief Commercial Officer 16 Feb 2024, 17:09
XFOR X4 Pharmaceuticals, Inc 01 Nov 2023 1 -$7.49K 4 Chief Commercial Officer 03 Nov 2023, 16:39
XFOR X4 Pharmaceuticals, Inc 31 Oct 2023 1 $0 4 Chief Commercial Officer 02 Nov 2023, 17:00
XFOR X4 Pharmaceuticals, Inc 03 Nov 2022 1 $644K 4 Chief Commercial Officer 04 Nov 2022, 16:18
XFOR X4 Pharmaceuticals, Inc 03 Nov 2022 0 $0 3 Chief Commercial Officer 04 Nov 2022, 16:15